share_log

There May Be Some Bright Spots In Repligen's (NASDAQ:RGEN) Earnings

There May Be Some Bright Spots In Repligen's (NASDAQ:RGEN) Earnings

Repligen(納斯達克股票代碼:RGEN)的收益可能有一些亮點
Simply Wall St ·  05/08 08:31

The market for Repligen Corporation's (NASDAQ:RGEN) shares didn't move much after it posted weak earnings recently. Our analysis suggests that while the profits are soft, the foundations of the business are strong.

Repligen公司(納斯達克股票代碼:RGEN)在最近公佈疲軟的收益後,其股票市場沒有太大波動。我們的分析表明,儘管利潤疲軟,但業務基礎卻很牢固。

earnings-and-revenue-history
NasdaqGS:RGEN Earnings and Revenue History May 8th 2024
NASDAQGS: RGEN 收益和收入歷史記錄 2024 年 5 月 8 日

The Impact Of Unusual Items On Profit

不尋常物品對利潤的影響

To properly understand Repligen's profit results, we need to consider the US$13m expense attributed to unusual items. While deductions due to unusual items are disappointing in the first instance, there is a silver lining. We looked at thousands of listed companies and found that unusual items are very often one-off in nature. And that's hardly a surprise given these line items are considered unusual. Repligen took a rather significant hit from unusual items in the year to March 2024. As a result, we can surmise that the unusual items made its statutory profit significantly weaker than it would otherwise be.

爲了正確了解Repligen的利潤業績,我們需要考慮歸因於不尋常項目的1300萬美元支出。儘管由於不尋常項目而產生的扣除首先令人失望,但有一線希望。我們調查了數千家上市公司,發現不尋常的物品本質上往往是一次性的。鑑於這些單列項目被認爲不尋常,這並不奇怪。在截至2024年3月的一年中,Repligen因不尋常的物品而遭受了相當大的打擊。因此,我們可以推測,這些不尋常的物品使其法定利潤明顯低於原來的水平。

That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.

這可能會讓你想知道分析師對未來盈利能力的預測。幸運的是,您可以單擊此處查看根據他們的估計描繪未來盈利能力的交互式圖表。

Our Take On Repligen's Profit Performance

我們對Repligen利潤表現的看法

As we discussed above, we think the significant unusual expense will make Repligen's statutory profit lower than it would otherwise have been. Because of this, we think Repligen's underlying earnings potential is as good as, or possibly even better, than the statutory profit makes it seem! On the other hand, its EPS actually shrunk in the last twelve months. Of course, we've only just scratched the surface when it comes to analysing its earnings; one could also consider margins, forecast growth, and return on investment, among other factors. So while earnings quality is important, it's equally important to consider the risks facing Repligen at this point in time. For example - Repligen has 3 warning signs we think you should be aware of.

正如我們上面討論的那樣,我們認爲巨額的異常支出將使Repligen的法定利潤低於原本的水平。因此,我們認爲Repligen的潛在盈利潛力與法定利潤看上去一樣好,甚至可能更好!另一方面,其每股收益實際上在過去十二個月中萎縮了。當然,我們只是在分析其收益時才浮出水面;人們還可以考慮利潤率、預測增長和投資回報率等因素。因此,儘管收益質量很重要,但考慮Repligen目前面臨的風險同樣重要。例如,Repligen 有 3 個警告信號,我們認爲你應該注意。

Today we've zoomed in on a single data point to better understand the nature of Repligen's profit. But there are plenty of other ways to inform your opinion of a company. Some people consider a high return on equity to be a good sign of a quality business. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying to be useful.

今天,我們放大了單個數據點,以更好地了解Repligen利潤的性質。但是,還有很多其他方法可以讓你對公司的看法。有些人認爲高股本回報率是優質業務的好兆頭。雖然可能需要你進行一些研究,但你可能會發現這份免費收集的擁有高股本回報率的公司,或者這份內部人士正在購買的股票清單很有用。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論